NDC 80739-812 – Krazati

Adagrasib 200 mg/1 · Tablet, Coated · Oral

Human Prescription Drug

Product NDC80739-812

Product details

Brand name
Krazati
Generic name
Adagrasib
Labeler
Mirati Therapeutics, Inc
Dosage form
Tablet, Coated
Route
Oral
Marketing category
NDA · NDA216340
Marketed since
December 12, 2022
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Krazati →

Package NDC codes (2)

Package NDCDescriptionSince
80739-812-121 BOTTLE in 1 CARTON (80739-812-12) / 120 TABLET, COATED in 1 BOTTLEDec 12, 2022
80739-812-181 BOTTLE in 1 CARTON (80739-812-18) / 180 TABLET, COATED in 1 BOTTLEDec 12, 2022